Search results for "Acute Coronary Syndrome"

showing 10 items of 277 documents

Iron deficiency and long-term mortality in elderly patients with acute coronary syndrome.

2018

Aim: We evaluated the relationship between iron deficiency (ID) and long-term mortality risk in elderly patients with acute coronary syndrome (ACS). Methods: In this prospective observational study, we included 252 patients older than 65 years with ACS. Transferrin saturation (TSAT) and ferritin were collected before discharge. Results: Mean age, hemoglobin and GRACE score were 78 ± 7 years, 12.4 ± 1.8 g/dl and 138.8 ± 25.3, respectively, 112(44.4%) patients were women, and 151(59.9%) presented ID. During the follow-up, 121 (48%) patients died. Mortality rates among TSAT quartiles were: 2.38, 1.60, 0.90 and 0.95 × 10 person-years for Q1TSAT to Q4TSAT, respectively (p < 0.001) and did no…

medicine.medical_specialtyAcute coronary syndromeClinical Biochemistry030204 cardiovascular system & hematologyGastroenterologyDisease-Free Survival03 medical and health sciences0302 clinical medicineInternal medicineDrug DiscoverymedicineHumans030212 general & internal medicineProspective StudiesAcute Coronary SyndromeAgedAged 80 and overbiologyTransferrin saturationbusiness.industryMortality rateBiochemistry (medical)TransferrinIron deficiencyIron Deficienciesmedicine.diseaseFerritinSurvival RateQuartileFerritinsbiology.proteinObservational studyHemoglobinbusinessBiomarkers in medicine
researchProduct

Predicting mortality with cardiac troponins: recent insights from meta-analyses.

2019

Abstract The introduction of cardiac troponin (cTn) testing in clinical practice has been one of the most important breakthroughs that have occurred in the recent history of laboratory medicine. Although it is now uncontestable that cTn values are essential for diagnosing acute coronary syndrome (ACS), solid evidence is also emerging that assessment of either cardiac troponin I (cTnI) or T (cTnT) may provide valuable prognostic information in the general healthy population, as well as in patients with a vast array of cardiac and extra-cardiac diseases. We have hence performed a critical review of the scientific literature for identifying meta-analyses which have investigated the potential c…

medicine.medical_specialtyAcute coronary syndromeClinical BiochemistryPopulationMedicine (miscellaneous)Disease030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicinedeath; mortality; prediction; troponinTroponin complexMeta-Analysis as TopicTroponin TInternal medicinedeathTroponin ImedicineHumans030212 general & internal medicineAcute Coronary Syndromeeducationeducation.field_of_studybiologybusiness.industrytroponinHealth PolicyBiochemistry (medical)Troponin IPublic Health Environmental and Occupational Healthpredictionmedicine.diseasePrognosisTroponinmortalityHeart failurebiology.proteinCardiologybusinessDiagnosis (Berlin, Germany)References
researchProduct

Diagnostic and prognostic value of H-FABP in acute coronary syndrome: Still evidence to bring

2018

Abstract The assessment of chest pain patients presenting to the emergency area (EA) is still a clinical challenge, as the majority of patients are not diagnosed with acute coronary syndrome (ACS). New generation high sensitivity c-Tn (hs-cTn) assays have showed better performances compared to the standard c-Tn. However, hs-Tn still presents some limitations. Hence, novel, early biomarkers are needed in this setting. Among all, heart-type fatty acid binding protein (H-FABP) has been largely investigated. This article reviews the studies evaluating H-FABP performance in diagnosing acute myocardial infarction (AMI) and stratifying chest pain patients by risk. H-FABP optimal performances in AC…

medicine.medical_specialtyAcute coronary syndromeClinical BiochemistryPredictive Value of Test030204 cardiovascular system & hematologyChest painClinical biochemistryAMIChest pain03 medical and health sciences0302 clinical medicinePredictive Value of TestsRule-inInternal medicinemedicineAnimalsHumans030212 general & internal medicineMyocardial infarctionAcute Coronary SyndromeRule-outAnimalbusiness.industrySmall sampleBiomarkerGeneral MedicineACSmedicine.diseasePredictive value of testsRisk stratificationH-FABPBiomarker (medicine)medicine.symptomTroponin CbusinessFatty Acid Binding Protein 3BiomarkersHumanClinical Biochemistry
researchProduct

Update on Ischemic Heart Disease and Critical Care Cardiology

2014

This article summarizes the main developments reported in 2013 on ischemic heart disease, together with the most important innovations in the management of acute cardiac patients. 3.792 JCR (2014) Q2, 34/123 Cardiac & cardiovascular systems UEM

medicine.medical_specialtyAcute coronary syndromeCritical Caremedicine.medical_treatmentEnfermedad cardiovascularMyocardial InfarctionMyocardial IschemiaDiseaseCardiologíaTratamiento médicoPercutaneous Coronary InterventionSex FactorsSex factorsInternal medicinemedicineHumansMyocardial infarctionAcute Coronary SyndromeIntensive care medicinePatofisiologíaSistema cardiovascularbusiness.industryAge FactorsPercutaneous coronary interventionGeneral Medicinemedicine.diseasePrognosisPrimary PreventionConventional PCICardiologycardiovascular systemPlatelet aggregation inhibitorInfarto de miocardiobusinessIschemic heartPlatelet Aggregation InhibitorsRevista Española de Cardiología (English Edition)
researchProduct

Utilidad de la troponina I para predecir la disfunción sistólica en los síndromes coronarios agudos. Resultados de un estudio prospectivo y cuantitat…

2003

The relationship between troponin I and systolic function (quantitative contrast ventriculography) was evaluated in 137 consecutive patients with a first acute coronary syndrome (60 with and 77 without ST elevation). In general, a larger troponin I peak value was related with a more depressed ejection fraction and poorer regional systolic function (p < 0.0001). Nevertheless, this correlation was weaker than expected, especially in those cases without ST-segment elevation, suggesting that other factors apart from systolic dysfunction must be taken into account in order to explain the worse prognosis of those patients with increased serum levels of this marker of myocardial damage.

medicine.medical_specialtyAcute coronary syndromeEjection fractionbiologyUnstable anginabusiness.industryST elevationmedicine.diseaseTroponinInternal medicinePredictive value of testsTroponin ImedicineCardiologybiology.proteinSystoleCardiology and Cardiovascular MedicinebusinessRevista Española de Cardiología
researchProduct

0326: Prognostic factors and impact of blood pressure level during the first 48 hours after myocardial infarction

2016

Background High blood pressure and low blood pressure are perfectly identified cardio-vascular risk factors, especially in primary prevention. However, their respective role after myocardial infarction is uncertain, with few data available. Objectives To compare cardio-vascular deaths and events after myocardial infarction between the different blood pressure levels observed during the first forty-eight hours. Methods We carried out an observational, prospective, monocentric study, including all consecutive patients admitted in Dijon’s Cardiologic Intensive Care Unit for myocardial infarction, between February 2012 and February 2014. Systolic blood pressure (SBP) was defined as the average …

medicine.medical_specialtyAcute coronary syndromeEjection fractionbusiness.industryBlood pressure level[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemPrognostic factorsmedicine.diseaseIntensive care unitlaw.inventionSurgeryMyocardial infarctionBlood pressurelawInternal medicineCardiologyMedicineObservational studycardiovascular diseasesMyocardial infarctionCardiology and Cardiovascular MedicinebusinessComputingMilieux_MISCELLANEOUSCardiovascular mortalityArchives of Cardiovascular Diseases Supplements
researchProduct

Acute Coronary Syndrome in the Older Patient

2021

Coronary artery disease is one of the leading causes of morbidity and mortality, and its prevalence increases with age. The growing number of older patients and their differential characteristics make its management a challenge in clinical practice. The aim of this review is to summarize the state-of-the-art in diagnosis and treatment of acute coronary syndromes in this subgroup of patients. This comprises peculiarities of ST-segment elevation myocardial infarction (STEMI) management, updated evidence of non-STEMI therapeutic strategies, individualization of antiplatelet treatment (weighting ischemic and hemorrhagic risks), as well as assessment of geriatric conditions and ethical issues in…

medicine.medical_specialtyAcute coronary syndromeInfarto del miocardio con elevación del STEnfermedad cardiovascularAncianoReviewCardiologíaMalalties coronàrieselderlyPersones gransacute coronary syndromeCoronary artery diseaseOlder patientsInfarto del miocardio sin elevación del STInternal medicineMedicineSíndrome coronario agudoMyocardial infarctioncardiovascular diseasesEthical issuesbusiness.industryRGeneral Medicinemedicine.diseaseClinical PracticeCoronary heart diseasemyocardial infarctionCardiologyMedicineOlder peoplebusinessJournal of Clinical Medicine
researchProduct

Abstract 3420: High-sensitivity Troponin T Improves Cardiovascular Risk Prediction In Patients With Cerebral Ischemia

2012

Background Patients with a cerebral ischemic event are at high risk of recurrent ischemia and other cardiovascular events. Clinical scores are recommended to predict cardiovascular risk in patients with cerebral ischemia to inform secondary preventive measures. Biomarkers may improve risk prediction beyond clinical scores and therefore secondary prevention. Methods Within the observational Find-AF trial (ISRCTN 46104198), 197 patients aged &gt;18 years with cerebral ischemia and without atrial fibrillation had blood sampled at baseline and completed 1-year follow-up. Predictive value of 5 novel cardiovascular biomarkers for a combined vascular endpoint (acute coronary syndrome, stroke, car…

medicine.medical_specialtyAcute coronary syndromeIschemia030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineModified Rankin ScaleInternal medicineMedicineStrokeAdvanced and Specialized NursingbiologyTroponin Tbusiness.industryHazard ratioAtrial fibrillationmedicine.diseaseTroponin3. Good healthSurgerybiology.proteinCardiologyNeurology (clinical)Cardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgeryStroke
researchProduct

Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome

2021

Ischemic heart disease (IHD) persists as the leading cause of death in the Western world. In recent decades, great headway has been made in reducing mortality due to IHD, based around secondary prevention. The advent of coronary revascularization techniques, first coronary artery bypass grafting (CABG) surgery in the 1960s and then percutaneous coronary intervention (PCI) in the 1970s, has represented one of the major breakthroughs in medicine during the last century. The benefit provided by these techniques, especially PCI, has been crucial in lowering mortality rates in acute coronary syndrome (ACS). However, in the setting where IHD is most prevalent, namely chronic coronary syndrome (CC…

medicine.medical_specialtyAcute coronary syndromeIschemic heart diseasemedicine.medical_treatmentstress cardiac magnetic resonancelcsh:MedicineChronic coronary syndromeReviewischemiaDisease030204 cardiovascular system & hematologyRevascularizationCoronary artery diseaseCoronary artery disease03 medical and health sciences0302 clinical medicineIschemiaInternal medicineMedicine030212 general & internal medicineCause of deathStress cardiac magnetic resonancechronic coronary syndromebusiness.industryMortality ratelcsh:RPercutaneous coronary interventionGeneral Medicinemedicine.diseaseischemic heart diseaseMyocardial revascularizationmyocardial revascularizationConventional PCICardiologybusinesscoronary artery diseaseJournal of Clinical Medicine
researchProduct

Non-invasive visualisation of coronary atherosclerosis: state-of-art.

2007

Coronary artery disease remains the leading cause of death in the Western world. Non-invasive coronary artery imaging challenges any diagnostic modality because the coronary arteries are small and tortuous, whereas cardiac contraction and respiration cause motion artifacts. Therefore, non-invasive coronary imaging requires high spatial and temporal resolution. This review discusses the feasible applications in coronary imaging of magnetic resonance imaging and multi-slice computed tomography (MSCT), which are currently the only non-invasive diagnostic modalities for direct coronary atherosclerosis imaging. Particular attention and focus is devoted to the potential indications and clinical i…

medicine.medical_specialtyAcute coronary syndromeLumen (anatomy)Coronary Artery DiseaseCoronary AngiographyCoronary artery diseaseImage Processing Computer-AssistedMedicineHumansCoronary atherosclerosismedicine.diagnostic_testCardiac cyclebusiness.industryMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingCoronary arteriesmedicine.anatomical_structureacute coronary syndrome coronary atherosclerosis coronary imaging multislice CT plaqueRadiologyCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedSettore MED/36 - Diagnostica Per Immagini E RadioterapiaArtery
researchProduct